Literature DB >> 1192618

Pathogenesis of malignant hypertension: experimental evidence from the renal hypertensive rat.

J Möhring.   

Abstract

In rats with unilateral renal artery stenosis, the malignant phase of hypertension is characterized by: systolic blood pressure above 180-190 mm Hg; sodium and water loss; polyuria and polydipsia; markedly activated renin-angiotensin-aldosterone system; impairment of renal function and malignant nephrosclerosis in the contralateral kidney; some rats exhibit signs of cerebral hemorrhage, heart failure, acute renal failure, and some rats die. After such a phase of malignant hypertension, a period of remission may occur, which is followed by another malignant phase, etc. When malignant hypertensive rats are offered, in addition to water, saline as drinking fluid, they compulsively drink the saline, BP falls transiently, and all signs of malignant hypertension nearly or completely disappear. These observations indicate that, at a critically high BP level, it is salt and water loss which, by activating the renin-angiotensin system, trigger the vicious circle of malignant renal hypertension in rats.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192618

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Vasoconstriction and increased blood pressure in the development of accelerated vascular disease.

Authors:  Z Nemes; R Dietz; J F Mann; J B Lüth; F Gross
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

2.  Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat.

Authors:  D Bradshaw; P H Franz; A L Sugden
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

3.  The failure of furosemide-induced salt and water loss to convert benign to malignant hypertension in the rat.

Authors:  S K Wilson; K Solez; R H Heptinstall
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

4.  Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway.

Authors:  San-Bin Xu; Bin Xu; Zhi-Heng Ma; Mei-Qin Huang; Zhi-Sheng Gao; Jian-Li Ni
Journal:  Nephrology (Carlton)       Date:  2022-07-05       Impact factor: 2.358

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.